| HOME >> BIOLOGY >> TECHNOLOGY |
Weight Heparin) Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2006
(includes corresponding Graph/Chart) 112
Table 32: European 11-Year Perspective for Anticoagulants by
Product Segment - Percentage Breakdown of Dollar Sales for
Oral Anticoagulants and Injectable Anticoagulants
(Unfractionated Heparin and Low Molecular Weight Heparin)
Markets for the Years 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 113
16a. FRANCE 114
Market Analysis 114
Table 33: French Recent Past, Current & Future Analysis for
Anticoagulants by Product Segment - Oral Anticoagulants and
Injectable Anticoagulants (Unfractionated Heparin and Low
Molecular Weight Heparin) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 114
Table 34: French Historic Review for Anticoagulants by
Product Segment - Oral Anticoagulants and Injectable
Anticoagulants (Unfractionated Heparin and Low Molecular
Weight Heparin) Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2006
(includes corresponding Graph/Chart) 115
Table 35: French 11-Year Perspective for Anticoagulants by
Product Segment - Percentage Breakdown of Dollar Sales for
Oral Anticoagulants and Injectable Anticoagulants
(Unfractionated Heparin and Low Molecular Weight Heparin)
Markets for the Years 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 116
16b. GERMANY 117
A.Market Analysis 117
Outlook 117
Market Drivers for Injectable Anticoagulants 117
Anticoagulants Growth Drive European POC Testing Market 117
B.Market Analytics 118
Table 36: German Recent Past, Current & Future Analysis for
Anticoagu
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |